Gene Synthesis Market to Grow with a CAGR of 9.76% through 2030F
Technological
advancements in the DNA synthesis platforms is expected to drive the Global Gene
Synthesis Market growth in the forecast period, 2026-2030F.
According
to TechSci Research report, “Gene Synthesis Market – Global Industry Size,
Share, Trends, Competition Forecast & Opportunities, 2030F”, the
Global Gene Synthesis Market stood at USD 1.84 Billion in 2024 and is expected
to reach USD 2.73 Billion by 2030 with a CAGR of 9.76% during the forecast
period.
The
declining price of DNA synthesis and sequencing has emerged as a significant
driver for the Gene Synthesis market, ushering in a new era of accessibility
and innovation in genetic research and biotechnology. This trend is
instrumental in reshaping the landscape of gene synthesis and expanding its
applications across various domains. First and foremost, the decreasing cost of
DNA synthesis services has democratized access to custom-designed genetic
constructs. Researchers, laboratories, and organizations with limited budgets
can now afford gene synthesis, enabling them to pursue a wider range of
scientific studies and biotechnological projects. As a result, the Gene
Synthesis market has witnessed increased demand from diverse stakeholders, from
academic institutions to startups and multinational corporations. In tandem
with DNA synthesis, the affordability of DNA sequencing technologies has also
played a crucial role. The decreasing cost of DNA sequencing enables
researchers to more readily validate and analyze the synthesized genes,
fostering greater confidence in experimental outcomes. This synergy between
synthesis and sequencing has created a virtuous cycle, where lower costs in
both domains drive greater utilization and innovation in gene synthesis projects.
Moreover, the declining prices of DNA synthesis and sequencing have accelerated
research and development efforts in genomics and personalized medicine. With
reduced financial barriers, scientists can conduct large-scale genomic studies,
uncover disease mechanisms, and develop targeted therapies. Gene synthesis is
at the forefront of these advances, providing the custom genetic material
necessary for such investigations.
Furthermore,
as the cost of sequencing genomes continues to drop, the demand for synthesized
genes for functional genomics and genome editing studies is on the rise.
Researchers use synthesized genes to understand gene function, create disease
models, and develop potential treatments, fueling the Gene Synthesis market's
growth. In conclusion, the declining prices of DNA synthesis and sequencing are
transformative drivers for the Gene Synthesis market. They enable broader
access to gene synthesis services, promote innovation, and accelerate
scientific discoveries in genomics, synthetic biology, and biotechnology. This
affordability trend is likely to continue to shape the future of genetic
research and biotechnological applications, fostering a dynamic and inclusive
environment for genetic innovation.
Browse
over XX market data Figures spread through XX Pages and an in-depth TOC
on "Global Gene Synthesis Market”
The
Global Gene Synthesis Market is segmented into method, service, application, end
use, regional distribution, and company.
In the
Global Gene Synthesis Market, the Gene & Cell Therapy Development segment
dominates due to the increasing adoption of synthetic genes for therapeutic
applications. The rising prevalence of genetic disorders, cancers, and chronic
diseases has fueled the demand for precise and customized gene sequences used
in cell and gene therapy. Advances in genome editing technologies, particularly
CRISPR-Cas9, have further strengthened the role of synthetic genes in targeted
treatments, driving significant investments from biotechnology and
pharmaceutical companies.
Gene
synthesis plays a critical role in engineered cell therapies, such as CAR-T
cell therapy, where modified genes are introduced into immune cells to enhance
their ability to fight diseases like leukemia and lymphoma. Similarly,
synthetic genes are essential in gene therapy applications, where they replace
faulty genes responsible for inherited disorders, such as cystic fibrosis and
sickle cell anemia. The ability to create highly specific and optimized genetic
constructs enables greater therapeutic efficacy, reducing risks of adverse
effects. Moreover, regulatory approvals and successful clinical trials have
encouraged the expansion of gene and cell therapy pipelines. With governments
and private investors funding research in regenerative medicine and precision
therapeutics, the demand for custom gene synthesis solutions is expected to
grow further. While vaccine development and disease diagnosis remain key
applications, the Gene & Cell Therapy Development segment leads the market,
benefiting from technological advancements and increasing adoption in precision
medicine.
Based
on region, after North America, Europe stands as the second dominating region
in the Global Gene Synthesis Market due to its strong biotechnology and
pharmaceutical industry, significant research funding, and well-established
regulatory framework supporting synthetic biology innovations. Countries such
as Germany, the United Kingdom, and France are at the forefront, driving
advancements in gene synthesis for applications in gene therapy, drug
development, and precision medicine. One of the primary reasons for Europe’s
dominance is the rising adoption of gene synthesis in personalized medicine and
rare disease treatments. With a growing focus on regenerative therapies and
genetic research, European pharmaceutical companies and research institutions
are heavily investing in synthetic biology. The European Union (EU) and
national governments provide substantial funding for genomics research,
fostering innovation in synthetic DNA technologies.
Additionally,
Europe’s strong biomanufacturing infrastructure supports large-scale production
of synthetic genes, which are crucial for biopharmaceuticals, vaccine
development, and genetic engineering. The region is also witnessing increased
collaboration between academic institutions and biotech firms to accelerate
gene synthesis advancements. Furthermore, favorable regulatory policies and
stringent quality standards ensure that gene synthesis technologies meet
ethical and safety requirements, facilitating market growth. While North
America remains the largest market, Europe’s technological progress, government
support, and increasing adoption of synthetic biology applications position it
as the second most dominant region in the Global Gene Synthesis Market.
Major
companies operating in Global Gene Synthesis Market are:
- OriGene
Technologies, Inc.
- Integrated
DNA Technologies, Inc.
- ProMab
Biotechnologies, Inc.
- Thermo
Fisher Scientific, Inc.
- ProteoGenix,
Inc.
- Biomatik
USA LLC
- Twist
Bioscience
- Boster
Biological Technology
- Brooks
Automation, Inc.
- Genscript
Corporation
Download Free Sample Report
Customers
can also request for 10% free customization on this report.
“The rising
adoption of enzymatic DNA synthesis (EDS) is transforming the Global Gene
Synthesis Market by offering a sustainable and efficient alternative to
traditional phosphoramidite-based chemical synthesis. EDS utilizes specialized
enzymes, such as DNA polymerases and terminal deoxynucleotidyl transferases, to
construct DNA strands in a more precise and environmentally friendly manner.
Unlike chemical synthesis, which relies on hazardous reagents and produces
toxic byproducts, EDS operates in aqueous solutions, significantly reducing its
ecological footprint. One of the key advantages of EDS is its ability to
synthesize longer and more complex DNA sequences with fewer errors. Traditional
methods often struggle with sequences beyond 200 base pairs, requiring
labor-intensive assembly techniques. In contrast, enzymatic synthesis enables
seamless, high-fidelity construction of extended DNA fragments, accelerating
research in genomics, synthetic biology, and personalized medicine. Additionally,
EDS enhances production efficiency, offering faster turnaround times by
eliminating the need for extensive post-synthesis processing. This speed
advantage is crucial for biotech companies and research institutions working on
time-sensitive projects, such as vaccine development and gene therapy
applications. As EDS technology continues to advance, it is expected to revolutionize
DNA synthesis, making it more scalable, cost-effective, and accessible for a
wide range of applications in healthcare, agriculture, and industrial
biotechnology.,” said Mr. Karan Chechi, Research Director of TechSci Research, a
research-based management consulting firm.
“Gene
Synthesis Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, By Method (Solid-phase Synthesis, Chip-based Synthesis, PCR-based
Enzyme Synthesis), By Service (Antibody DNA Synthesis, Viral DNA Synthesis,
Others), By Application (Gene & Cell Therapy Development, Vaccine
Development, Disease Diagnosis, Others), By End Use (Biotechnology and
Pharmaceutical Companies, Academic and Government Research Institutes, Contract
Research Organizations), By Region and Competition, 2020-2030F”, has
evaluated the future growth potential of Global Gene Synthesis Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Gene Synthesis Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com